Abbott's Solvay Drug-Unit Purchase Reduces Dependence on Humira.
Abbott Laboratories' purchase of Solvay SA's pharmaceutical unit, for about 4.8 billion euros ($7.1 billion), will give it full control of the TriCor cholesterol drug and ...
Full Story